Antibody neutralization of microbiota-derived circulating peptidoglycan dampens inflammation and ameliorates autoimmunity.
Animals
Antibodies, Neutralizing
/ administration & dosage
Arthritis
/ drug therapy
Autoimmunity
/ drug effects
Bacteria
/ immunology
Encephalomyelitis
/ drug therapy
Female
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Inbred DBA
Microbiota
Nod2 Signaling Adaptor Protein
/ genetics
Peptidoglycan
/ blood
Journal
Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
22
02
2018
accepted:
18
01
2019
pubmed:
6
3
2019
medline:
27
6
2019
entrez:
6
3
2019
Statut:
ppublish
Résumé
The human microbiota provides tonic signals that calibrate the host immune response
Identifiants
pubmed: 30833732
doi: 10.1038/s41564-019-0381-1
pii: 10.1038/s41564-019-0381-1
doi:
Substances chimiques
Antibodies, Neutralizing
0
Nod2 Signaling Adaptor Protein
0
Nod2 protein, mouse
0
Peptidoglycan
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
766-773Commentaires et corrections
Type : CommentIn
Références
Schroeder, B. O. & Bäckhed, F. Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med. 22, 1079–1089 (2016).
doi: 10.1038/nm.4185
Grigg, J. B. & Sonnenberg, G. F. Host-microbiota interactions shape local and systemic inflammatory diseases. J. Immunol. 198, 564–571 (2017).
doi: 10.4049/jimmunol.1601621
Kotani, S., Watanabe, Y., Kinoshita, F., Shimono, T. & Morisaki, I. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J. 18, 105–111 (1975).
pubmed: 1180867
Löwy, I., Bona, C. & Chedid, L. Target cells for the activity of a synthetic adjuvant: muramyl dipeptide. Cell. Immunol. 29, 195–199 (1977).
doi: 10.1016/0008-8749(77)90288-X
Xu, X. L. et al. Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe 4, 28–39 (2008).
doi: 10.1016/j.chom.2008.05.014
Behr, M. A. & Divangahi, M. Freund’s adjuvant, NOD2 and mycobacteria. Curr. Opin. Microbiol. 23, 126–132 (2015).
doi: 10.1016/j.mib.2014.11.015
Alexander, K. L., Targan, S. R. & Elson, C. O. 3rd Microbiota activation and regulation of innate and adaptive immunity. Immunol. Rev. 260, 206–220 (2014).
doi: 10.1111/imr.12180
Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965–977 (2015).
doi: 10.1038/nn.4030
Rogers, G. B. Germs and joints: the contribution of the human microbiome to rheumatoid arthritis. Nat. Med. 21, 839–841 (2015).
doi: 10.1038/nm.3916
Lee, W. J. & Hase, K. Gut microbiota-generated metabolites in animal health and disease. Nat. Chem. Biol. 10, 416–424 (2014).
doi: 10.1038/nchembio.1535
den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325–2340 (2013).
doi: 10.1194/jlr.R036012
Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
doi: 10.1126/science.1223813
Dworkin, J. The medium is the message: interspecies and interkingdom signaling by peptidoglycan and related bacterial glycans. Annu. Rev. Microbiol. 68, 137–154 (2014).
doi: 10.1146/annurev-micro-091213-112844
Johnson, J. W., Fisher, J. F. & Mobashery, S. Bacterial cell-wall recycling. Ann. N. Y. Acad. Sci. 1277, 54–75 (2013).
doi: 10.1111/j.1749-6632.2012.06813.x
Clarke, T. B. et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16, 228–231 (2010).
doi: 10.1038/nm.2087
Caruso, R., Warner, N., Inohara, N. & Núñez, G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 41, 898–908 (2014).
doi: 10.1016/j.immuni.2014.12.010
Philpott, D. J., Sorbara, M. T., Robertson, S. J., Croitoru, K. & Girardin, S. E. NOD proteins: regulators of inflammation in health and disease. Nat. Rev. Immunol. 14, 9–23 (2014).
doi: 10.1038/nri3565
Girardin, S. E. et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584–1587 (2003).
doi: 10.1126/science.1084677
Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869–8872 (2003).
doi: 10.1074/jbc.C200651200
Rosenberg-Hasson, Y., Hansmann, L., Liedtke, M., Herschmann, I. & Maecker, H. T. Effects of serum and plasma matrices on multiplex immunoassays. Immunol. Res. 58, 224–233 (2014).
doi: 10.1007/s12026-014-8491-6
Li, Y. et al. Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi. Nat. Med. 22, 952–960 (2016).
doi: 10.1038/nm.4139
Brand, D. D., Kang, A. H. & Rosloniec, E. F. The mouse model of collagen-induced arthritis. Methods Mol. Med. 102, 295–312 (2004).
pubmed: 15286392
Khachigian, L. M. Collagen antibody-induced arthritis. Nat. Protoc. 1, 2512–2516 (2006).
doi: 10.1038/nprot.2006.393
Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173–6177 (2003).
doi: 10.4049/jimmunol.171.11.6173
Miller, S. D., Karpus, W. J. & Davidson, T. S. Experimental autoimmune encephalomyelitis in the mouse. Curr. Protoc. Immunol. Chapter 15, Unit 15.1 (2010).
pubmed: 20143314
Nachbur, U. et al. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. Nat. Commun. 6, 6442 (2015).
doi: 10.1038/ncomms7442
Cloud-Hansen, K. A. et al. Breaching the great wall: peptidoglycan and microbial interactions. Nat. Rev. Microbiol. 4, 710–716 (2006).
doi: 10.1038/nrmicro1486
Dagil, Y. A. et al. The dual NOD1/NOD2 agonism of muropeptides containing a meso-diaminopimelic acid residue. PLoS ONE 11, e0160784 (2016).
doi: 10.1371/journal.pone.0160784
Girardin, S. E. et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278, 41702–41708 (2003).
doi: 10.1074/jbc.M307198200
Hnasko, R. M. & Stanker, L. H. Hybridoma technology. Methods Mol. Biol. 1318, 15–28 (2015).
doi: 10.1007/978-1-4939-2742-5_2